ET

Eliem Therapeutics

CLYM
NASDAQHealth Care

Insider Trades

clym
2 months ago

Stephen Basil Thomas sold 33,687 shares of CLYM on 25 February. They now own 170,970 CLYM shares, or a 16% holding decrease.

Stephen Basil Thomas sold CLYM
clym
2 months ago

Stephen Basil Thomas sold 16,313 shares of CLYM on 26 February. They now own 154,657 CLYM shares, or a 10% holding decrease.

Stephen Basil Thomas sold CLYM
clym
2 months ago

Stephen Basil Thomas sold 90,000 shares of CLYM on 12 February. They now own 214,657 CLYM shares, or a 30% holding decrease.

Stephen Basil Thomas sold CLYM
clym
4 months ago

Emily Pimblett sold 1,235 shares of CLYM on 19 December. They now own 11,329 CLYM shares, or a 10% holding decrease.

Emily Pimblett sold CLYM
clym
5 months ago

RA Capital Healthcare Fund LP bought 213,099 shares of CLYM on 11 December. They now own 3,294,856 CLYM shares, or a 7% holding increase.

RA Capital Healthcare Fund LP bought CLYM
clym
10 months ago

Aoife Brennan sold 20,618 shares of CLYM on 30 June. They now own 48,132 CLYM shares, or a 30% holding decrease.

Aoife Brennan sold CLYM
clym
10 months ago

Emily Pimblett sold 1,242 shares of CLYM on 20 June. They now own 18,888 CLYM shares, or a 6% holding decrease.

Emily Pimblett sold CLYM
clym
1 year ago

Emily Pimblett sold 1,199 shares of CLYM on 20 March. They now own 15,130 CLYM shares, or a 7% holding decrease.

Emily Pimblett sold CLYM
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...